Not another glucosamine product. Cetyl myristoleate works through enzyme inhibition and immune modulation — a different mechanism entirely, with an honest reading of the evidence behind it.
Total CMO is not a glucosamine product. Cetyl myristoleate carries no cartilage building blocks and works instead through enzyme pathway inhibition and immune modulation, strongest in autoimmune joint disease rather than simple wear. Real peer-reviewed evidence exists, and the widely-cited 63% and 87% figures were never peer-reviewed.
Glucosamine and chondroitin supply raw material for cartilage rebuilding. Fish oil shifts prostaglandin balance. Both work through one lever — supplying substrate. Cetyl myristoleate contains no cartilage building blocks at all.
It's proposed to work through enzyme pathway inhibition, synovial lubrication, and immune modulation at the joint. It does not compete with a structural formula like Total JT Plus or Complete FM — it addresses what neither of them reaches.
The strongest clinical rationale is autoimmune joint disease, where the immune system is actively attacking joint tissue rather than the joint simply wearing down. Glucosamine non-responders after three or more months, morning stiffness over thirty minutes, and multiple joints inflamed simultaneously are the signals pointing here.
| Mechanism | What Is Known |
|---|---|
| Enzyme pathway inhibition best supported | Proposed to inhibit both cyclooxygenase and lipoxygenase pathways of arachidonic acid metabolism, reducing prostaglandins and leukotrienes that drive joint pain and swelling. Same general category of action as Total FLM, through a different molecular structure — which is why the two are complementary rather than redundant. |
| Joint lubrication proposed, less direct support | A long-chain fatty acid ester with surfactant-like properties, suggested to support synovial fluid production and viscosity. Avascular cartilage depends on synovial fluid for nutrient delivery, and degraded lubrication increases mechanical wear. Less direct human trial support than the anti-inflammatory action. |
| Immune modulation hypothesis, least certain | Proposed interaction with immune cell membranes shifting T-cell activity toward a more tolerant pattern, which would explain reports of more durable response in autoimmune arthritis than in osteoarthritis. A genuine hypothesis rather than established science. Newer research proposes an alternative or additional mechanism via monoacylglycerol lipase inhibition, connecting cetylated fatty acids to the endocannabinoid system. Neither explanation is settled. |
The honest summary: real peer-reviewed positive evidence exists for oral and topical cetylated fatty acids in osteoarthritis. The most frequently cited figures — 63 and 87 percent improvement — come from a large trial never published in a peer-reviewed journal. Independent replication confirmed the mechanism is real while finding a smaller effect than first reported. Both facts belong in how this product gets presented.
| Study or Claim | What It Showed | Rating |
|---|---|---|
| Diehl, J Pharm Sci 1994 | The original animal finding. CMO isolated from resistant Swiss albino mice blocked adjuvant-induced arthritis in susceptible rat strains. Peer-reviewed. | Established animal finding |
| Siemandi, Townsend Letter 1997 | 382 patients, randomized, double-blind, placebo-controlled. CMO-only group 63% improved; CMO plus glucosamine/sea cucumber/hydrolyzed cartilage group 87%; placebo 14%. Substantial trial size and design, published in a trade publication for practitioners rather than a peer-reviewed medical journal, not independently replicated at that scale. | Large positive trial, NOT peer-reviewed |
| Hesslink, J Rheumatol 2002 | Peer-reviewed. Cetylated fatty acids improved knee function in osteoarthritis patients. The strongest independently published human evidence for this compound category. | Positive, peer-reviewed |
| Kraemer, J Rheumatol 2004 | Peer-reviewed. Cetylated fatty acid topical cream improved functional mobility and quality of life in osteoarthritis. Same research group, topical route. | Positive, peer-reviewed, topical |
| Hunter/Gault/Tam-Chang, Pharmacol Res 2003 | Independent lab synthesized pure CMO and tested it specifically to verify the 1994 findings, in a collagen-induced arthritis model. Confirmed anti-arthritic activity by injection and oral dosing. Stated directly that the effect was less dramatic than originally reported. | Confirmed, smaller effect than original claims — the single most trustworthy data point in the literature |
| 2006 review, Arthritis Research and Therapy | A broader nutraceutical review found the evidence for cetyl myristoleate limited, alongside several other natural compounds reviewed at the same time. | Limited, per independent review |
| Regulatory history | CMO marketers have faced FTC enforcement action over claims exceeding what the evidence supports. Does not invalidate the legitimate research, but is a reason to describe this compound carefully. | Documented history of overstated marketing claims |
Each tablet: molybdenum (as chelate) 2mcg, CMO (cetyl myristoleate) 250mg. That's the entire active content — no proprietary blend obscuring the dose, no filler ingredients dressed up as actives.
One detail worth knowing before dosing: the manufacturer's own product description states directly, "We recommend you also use Total FLM." Total FLM's own record states the reverse: "We recommend you add Total CMO." This is a stated manufacturer pairing in both directions, not a clinical inference someone worked out afterward.
The label says one tablet daily. Dr. Frazier's approach starts at one tablet daily to establish tolerance and get a baseline read before increasing. The standard therapeutic tier for most active presentations is one tablet twice daily. Sustained inflammatory load or a partial response at standard tier moves to one tablet three times daily. The higher-demand tier — two tablets twice daily — is reserved for clearly active autoimmune presentation or a case not responding at lower tiers, and is reassessed regularly rather than continued indefinitely without review.
As a fatty acid ester, absorption is generally improved when taken with a meal containing some fat. Worth knowing: the historical literature, including the Siemandi trial, generally used defined multi-week courses rather than open-ended continuous dosing. The tiers above reflect current working protocol rather than a fixed loading schedule.
Because chiropractic addresses the mechanical and neurological side of joint health no supplement reaches. Joint capsule mechanoreceptors feed proprioceptive and afferent input to the central nervous system, and restricted joint motion alters that signaling in ways that influence local autonomic tone and pain perception at the segmental level.
Restoring normal joint motion also improves synovial fluid circulation, since movement itself distributes that fluid across cartilage surfaces, and normal biomechanics reduce the abnormal loading patterns that drive further inflammatory signaling. Class IV laser and Emsculpt Neo address pain relief and surrounding muscular support directly, considered in any chronic pain protocol touching a joint this formula works on from the immune side.
Two minutes on the conversion step a single marker cannot report. Narrated from Dr. Troy Delane Frazier’s own clinical writing on this formula — his reasoning, his words.
Narrated summary of Dr. Frazier’s clinical rationale. Nothing plays until you click — no tracking loads on page view.
Yes, and this page states both facts plainly rather than hoping you don't look them up yourself.
Marketers of cetyl myristoleate products have faced FTC enforcement action for claims exceeding what the evidence supports. The most widely circulated statistics for this ingredient category — 63% and 87% improvement — come from a 382-patient trial that was never published in a peer-reviewed medical journal, only in a trade publication for practitioners. Those are real, documented facts about this category, and a page trying to sell you on this product would have every incentive to leave them out.
Here's what doesn't get erased by that history: an independent lab, with no stake in the original trial's outcome, synthesized pure CMO specifically to test whether the underlying claim held up. It did — the anti-arthritic mechanism was confirmed — but the effect was smaller than originally reported. Two additional peer-reviewed human trials, published in a real rheumatology journal, found genuine positive results. The honest position isn't "ignore this ingredient" or "trust the 87% figure." It's "the mechanism is real, and the original headline number oversold it."
Because they work through completely different mechanisms, and glucosamine doesn't address what this formula targets. If you've already tried a structural, cartilage-focused approach for three or more months without relief — particularly with morning stiffness over thirty minutes or multiple joints involved simultaneously — that's specifically the pattern pointing toward an immune-mediated component rather than simple wear, which is where this formula's actual evidence base sits.
Testimonials reflect individual experiences and are not a guarantee of any clinical outcome.
| Each Tablet Contains | Amount |
|---|---|
| Molybdenum (as chelate) | 2 mcg |
| CMO (cetyl myristoleate) | 250 mg |
Other ingredients: Dicalcium phosphate, microcrystalline cellulose, tricalcium phosphate, vegetable stearine, vegetable magnesium stearate, vegetable stearic acid. No proprietary blend obscuring the dose.
Not vegetarian or vegan — vegan status is not declared or verified by the manufacturer. No declared allergens. No known contraindications on the manufacturer label.
Suggested use: 1 tablet daily, or as directed. Absolute Health standard is 1 tablet twice daily; extended tier 3 times daily; higher-demand tier 2 tablets twice daily, reassessed regularly. Take with a meal containing some fat — absorption of this fatty acid ester improves with dietary fat present.
Cautions: autoimmune conditions require real medical management under a rheumatologist; this is complementary support, not a substitute, and needs coordination if you're on immunosuppressive or biologic therapy. Fatty acid derivatives generally warrant awareness on anticoagulant or antiplatelet therapy, though no specific interaction is documented for this compound. No specific contraindication is declared in pregnancy or nursing, but the research base in these populations does not exist — practitioner direction rather than self-initiation is appropriate.
Refer out: new-onset, multi-joint, or systemic joint pain warrants proper medical evaluation before this product is added, not instead of it.
| Product | Role and Dose | Cautions and Allergens |
|---|---|---|
| Total FLM manufacturer-endorsed standing pair | Boswellia, turmeric, ginger, quercetin, glutathione and alpha lipoic acid work the inflammatory cascade through a different route, addressing the fire while CMO addresses the immune signal underneath it. 1 tablet daily or as directed. | Vegan, gluten free, no declared allergens, no known contraindications. |
| Total JT Plus | Where structural cartilage support is also needed. Glucosamine sulfate and the amino acid matrix supply building material CMO does not provide. Complementary, not overlapping. | Contains shellfish (green lipped mussel) and bovine trachea. Not vegetarian or vegan. |
| Complete FM | The enzyme-forward structural alternative to Total JT Plus. Glucosamine sulfate alongside proteolytic enzymes, providing building material and an additional anti-inflammatory route when dosed away from food. | Contains egg and soybean. Not vegetarian or vegan. Adds to cumulative glucosamine if run alongside Total JT Plus. |
Products not yet linked will become live pages as they clear the clinical and schema review gate.
Four stages. Each one builds on what the last one found — you paste the AI’s answer back in and the next prompt is written around it. You end with a document you can take to a doctor. This is education, not diagnosis.
Before anything else — what is actually happening underneath the symptom. This stage translates what you feel into the biological systems involved.
Your prompt will appear here.
Now the specifics of your case, written against what stage one found.
Complete stage 01 to unlock
Your prompt will appear here.
A visual of your own picture — the pathway involved and where this formula enters it. Paste into an image-capable AI.
Complete stage 02 to unlock
Your prompt will appear here.
Image generators garble dense text. Proof the rendered image before showing it to anyone.
Everything above, assembled into a document you can actually read and understand — what may be happening underneath, how this formula applies to you, and the questions to ask before you book.
Complete stage 03 to unlock
Your prompt will appear here.
Not every practice works at this level, and there is no fault in that — it is a different training. Ask these on the phone before you pay for a visit. If the answers are no, you have saved yourself an appointment.
If your provider referred you here, take the dossier to them — it is built to make that visit better. If you don’t have a provider working in this lane, Dr. Troy Delane Frazier, DC sees patients by telehealth and this is exactly the conversation he has been having since 1998.
Call to Schedule · (801) 221-1151Telehealth availability varies by state. Absolute Health, Orem, Utah.
No, and the mechanism is genuinely different, not just a different ingredient doing the same job. Glucosamine and chondroitin supply raw material for cartilage rebuilding. Fish oil shifts prostaglandin balance. Both work through one lever. Cetyl myristoleate contains no cartilage building blocks at all and is proposed to work through enzyme pathway inhibition, synovial lubrication, and immune modulation at the joint. It does not compete with a structural product like Total JT Plus — it addresses what neither a structural nor an omega-3 approach reaches.
The trial is real; its publication status is the part that needs stating plainly. Those figures come from a 382-patient randomized, double-blind, placebo-controlled trial published in the Townsend Letter in 1997 — a substantial trial by design and size, but a trade publication for practitioners rather than a peer-reviewed medical journal, and it has not been independently replicated at that scale. An independent lab later synthesized pure CMO specifically to verify the original findings, confirmed the anti-arthritic mechanism was real, and found a smaller effect than originally reported. Both facts belong in how this product gets presented, and neither one cancels the other out.
The strongest clinical rationale is autoimmune joint disease — where the immune system is actively attacking joint tissue, rather than the joint simply wearing down over time. Glucosamine non-responders after three or more months, morning stiffness lasting over thirty minutes, and multiple joints inflamed simultaneously are the signals pointing here rather than toward a structural, cartilage-focused approach.
Yes, and it's worth knowing rather than glossing over. Marketers of cetyl myristoleate products have faced FTC enforcement action over claims exceeding what the evidence actually supports. That history doesn't invalidate the legitimate peer-reviewed research that does exist — it's a reason to describe this compound carefully rather than repeat the more dramatic marketing claims that got other companies in trouble.
Because the manufacturer states the pairing in both directions, not as a clinical inference someone worked out afterward — Total CMO's own product record recommends adding Total FLM, and Total FLM's record recommends adding Total CMO. Total FLM's boswellia, turmeric, ginger, quercetin, glutathione and alpha lipoic acid work the inflammatory cascade through a different route entirely, addressing the fire while CMO addresses the immune signal underneath it.
Only as a complement to real medical management, never as a substitute for it. Rheumatoid arthritis, psoriatic arthritis and related conditions are managed with disease-modifying medication under a rheumatologist, and this product is complementary support at most. Anyone on immunosuppressive or biologic therapy needs this coordinated with their treating physician before adding it, not decided independently.
No. Total CMO is dispensed by Dr. Troy Delane Frazier, DC at Absolute Health, 560 South State Street, Suite H-1, Orem, Utah 84058, and ships nationwide. If your own provider referred you, enter their Referring Provider ID at checkout so the order is credited to them. Questions: (801) 221-1151.
90 tablets · cetyl myristoleate joint and immune support
Not vegetarian · No declared allergens · Ships nationwide
Personalized product matches based on your goals